Xu Qiaxin, Xiao Zeyu, Yang Qianzhi, Yu Tingting, Deng Xiujiao, Chen Nenghua, Huang Yanyu, Wang Lihong, Guo Jun, Wang Jinghao
Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
The Guangzhou Key Laboratory of Basic and Translational Research on Chronic Diseases, Jinan University, Guangzhou, 510630, China.
Mater Today Bio. 2024 Feb 13;25:100978. doi: 10.1016/j.mtbio.2024.100978. eCollection 2024 Apr.
A life-threatening illness that poses a serious threat to human health is myocardial infarction. It may result in a significant number of myocardial cells dying, dilated left ventricles, dysfunctional heart function, and ultimately cardiac failure. Based on the development of emerging biomaterials and the lack of clinical treatment methods and cardiac donors for myocardial infarction, hydrogels with good compatibility have been gradually applied to the treatment of myocardial infarction. Specifically, based on the three processes of pathophysiology of myocardial infarction, we summarized various types of hydrogels designed for myocardial tissue engineering in recent years, including natural hydrogels, intelligent hydrogels, growth factors, stem cells, and microRNA-loaded hydrogels. In addition, we also describe the heart patch and preparation techniques that promote the repair of MI heart function. Although most of these hydrogels are still in the preclinical research stage and lack of clinical trials, they have great potential for further application in the future. It is expected that this review will improve our knowledge of and offer fresh approaches to treating myocardial infarction.
心肌梗死是一种对人类健康构成严重威胁的危及生命的疾病。它可能导致大量心肌细胞死亡、左心室扩张、心脏功能失调,并最终导致心力衰竭。基于新兴生物材料的发展以及心肌梗死临床治疗方法和心脏供体的缺乏,具有良好相容性的水凝胶已逐渐应用于心肌梗死的治疗。具体而言,基于心肌梗死病理生理学的三个过程,我们总结了近年来为心肌组织工程设计的各类水凝胶,包括天然水凝胶、智能水凝胶、生长因子、干细胞以及负载微小RNA的水凝胶。此外,我们还描述了促进心肌梗死心脏功能修复的心脏贴片及其制备技术。尽管这些水凝胶大多仍处于临床前研究阶段且缺乏临床试验,但它们在未来具有巨大的进一步应用潜力。预计这篇综述将增进我们对治疗心肌梗死的认识并提供新的方法。